Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding NPRNovo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York TimesWegovy maker Novo's profit warning triggers $70 billion share rout ReutersNovo Stock (NVO) Tumbles. Ozempic, Wegovy Maker Has New CEO, Cuts U.S. Outlook Barron's
|